March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Arginase 2 Deficiency Limits Microglia/Macrophage Activation and Prevents Hyperoxia-induced Vascular Injury in the Mouse Retina
Author Affiliations & Notes
  • Jutamas Suwanpradid
    Vascular Biology Center,
    Georgia Health Sciences University, Augusta, Georgia
  • Zhimin Xu
    Vascular Biology Center,
    Georgia Health Sciences University, Augusta, Georgia
  • Subhadra P. Narayanan
    Vascular Biology Center,
    Georgia Health Sciences University, Augusta, Georgia
  • Robert W. Caldwell
    Department of Pharmacology and Toxicology,
    Georgia Health Sciences University, Augusta, Georgia
  • Ruth B. Caldwell
    Vascular Biology Center,
    Georgia Health Sciences University, Augusta, Georgia
    VA Medical Center, Augusta, Georgia
  • Footnotes
    Commercial Relationships  Jutamas Suwanpradid, None; Zhimin Xu, None; Subhadra P. Narayanan, None; Robert W. Caldwell, None; Ruth B. Caldwell, None
  • Footnotes
    Support  NEI-R01-EY04618, NEI-R01-EY11766, VA Merit Review, AHA 11PRE7940015
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5882. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jutamas Suwanpradid, Zhimin Xu, Subhadra P. Narayanan, Robert W. Caldwell, Ruth B. Caldwell; Arginase 2 Deficiency Limits Microglia/Macrophage Activation and Prevents Hyperoxia-induced Vascular Injury in the Mouse Retina. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5882.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Excessive activity of the urea cycle enzyme arginase has been suggested to play an important role in vascular injury during cardiovascular diseases. Our lab is investigating whether this enzyme could serve as a therapeutic target in retinal vascular disease. Our previous studies showed that deletion of arginase 2 (A2) enhances physiological vascular repair in a mouse model of oxygen-induced retinopathy. Now, we have examined the involvement of A2 in hyperoxia-induced vascular injury and explored the role of macrophage/microglia in the pathological process.

Methods: : Mice (A2ko, WT) were placed in 70% oxygen from p7-p12 and then returned to room air. The hyperoxia exposure causes obliteration of the developing vessels which leads to a condition of relative ischemia upon return to normal oxygen environment. Mice were sacrificed at different times during or after the hyperoxia treatment and their retinas were processed to determine the effects of arginase deletion on vaso-obliteration in relation to the distribution of microglia/macrophage cells and oxidative stress.

Results: : Measurement of the central avascular zone after 24 hrs of hyperoxia treatment showed that the area of vaso-obliteration in the retinas of A2ko mice was significantly smaller than that in the WT (26% vs 31%, P<0.05) indicating that vascular survival is improved. The vasoprotective effect of A2 deletion continued during the hypoxic phase and at p17 the avascular area and average size of neovascular tufts were significantly reduced (by 2.2 and 4.7 fold, respectively, P<0.05). This vasoprotective effect in the A2ko retina was associated with a decrease in the formation of superoxide and peroxynitrite along with a significant increase in the ratio of resting microglia to activated microglia/macrophage as compared with the retinas of hyperoxia-treated WT mice (P<0.05).

Conclusions: : Arginase 2 plays a key role in hyperoxia-induced retinal vascular injury through a mechanism involving formation of superoxide and peroxynitrite and activation of microglia/macrophage cells.

Keywords: oxidation/oxidative or free radical damage • signal transduction • microglia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×